XenoHelix (CEO Sung-wook Yang) successfully attracted a large number of visitors with its differentiated skincare materials, Exosome and PDRN, at the 2026 Cosmetic Inside Korea exhibition held at KINTEX in Ilsan from March 31 to April 3.

Leveraging its proprietary XENOPURE® platform technology, which isolates and purifies nucleic acids—specifically miRNA—XenoHelix has been expanding its domestic and international sales networks. The company develops plant callus exosomes, distinctive natural exosomes, and miPDRN, an ultra-low-molecular-weight PDRN specialized for skin penetration.

Alongside the commercialization of these unique skincare materials, XenoHelix captured the attention of brands and OEM companies through its advanced technical capabilities. The company goes beyond simple material development by identifying exosome biomarkers and researching the mechanisms of action behind miPDRN, delivering true technological value to partners and end consumers.

According to the company, its natural exosome not only delivers skin regeneration benefits but also demonstrates anti-hair loss efficacy, with tests confirming a 170% increase in hair shaft thickness.

"Based on our extensive R&D experience, we are highly focused on developing innovative materials," said CEO Sung-wook Yang. "Following our salmon-derived miPDRN, we have continuously expanded our application technology to include Vegan miPDRN. We will continue to maintain strong partnerships with global brand companies and do our utmost to drive the global expansion of K-beauty materials."